CRIS Current Research Information System

GALVANI, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.868
EU - Europa 1.231
NA - Nord America 1.107
AF - Africa 155
SA - Sud America 66
OC - Oceania 1
Totale 4.428
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.081
VN - Vietnam 698
IT - Italia 602
SG - Singapore 419
CN - Cina 353
HK - Hong Kong 134
GB - Regno Unito 130
DE - Germania 119
NL - Olanda 78
FR - Francia 73
BR - Brasile 51
IN - India 49
KR - Corea 48
FI - Finlandia 40
SC - Seychelles 40
CI - Costa d'Avorio 39
IE - Irlanda 34
JP - Giappone 34
SE - Svezia 31
TG - Togo 30
ZA - Sudafrica 28
ES - Italia 22
RU - Federazione Russa 20
TH - Thailandia 20
CH - Svizzera 18
PH - Filippine 18
BG - Bulgaria 16
CA - Canada 16
AT - Austria 13
ID - Indonesia 13
JO - Giordania 13
PL - Polonia 13
PK - Pakistan 12
BD - Bangladesh 11
TR - Turchia 11
TW - Taiwan 10
MX - Messico 9
BE - Belgio 5
AE - Emirati Arabi Uniti 4
AR - Argentina 4
EG - Egitto 3
HR - Croazia 3
IQ - Iraq 3
IR - Iran 3
MA - Marocco 3
MY - Malesia 3
NG - Nigeria 3
PE - Perù 3
UZ - Uzbekistan 3
CL - Cile 2
CO - Colombia 2
DZ - Algeria 2
EC - Ecuador 2
GH - Ghana 2
LT - Lituania 2
PT - Portogallo 2
RO - Romania 2
TN - Tunisia 2
AM - Armenia 1
AU - Australia 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
IS - Islanda 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
LY - Libia 1
MM - Myanmar 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
Totale 4.428
Salva come PNG Salva come JPEG
Città #
Singapore 333
Bologna 208
Ho Chi Minh City 191
Hanoi 156
Ashburn 155
Hong Kong 112
Chandler 106
Hefei 106
San Jose 101
Bristol 45
Dallas 45
Seoul 43
Fairfield 42
Frankfurt am Main 40
Abidjan 39
Council Bluffs 39
Helsinki 36
Southend 34
Dublin 33
Los Angeles 33
Boardman 31
Santa Clara 31
Lomé 30
Islington 29
Lauterbourg 29
Redmond 29
Trento 29
Beijing 28
Ann Arbor 27
Dong Ket 26
Da Nang 25
Tokyo 25
Haiphong 24
Johannesburg 23
Turin 22
Amsterdam 20
Milan 20
New York 20
Munich 18
Princeton 18
Marano 16
Sofia 16
Bern 15
Houston 15
Jerez De La Frontera 15
Modena 14
Amman 13
Argelato 13
Paris 11
Seattle 11
Vienna 11
Wilmington 11
Cambridge 10
Forlì 10
Hải Dương 10
Jakarta 10
Nha Trang 10
San Diego 10
Woodbridge 10
Bengaluru 9
Berlin 9
Bolzano 9
Buffalo 9
Florence 9
Warsaw 9
Redondo Beach 8
Rome 8
Bangkok 7
Biên Hòa 7
Castel Maggiore 7
Des Moines 7
Long Xuyen 7
Parma 7
Điện Bàn 7
Bari 6
Can Tho 6
Cesena 6
Chicago 6
Medford 6
Quận Một 6
Shenzhen 6
Toronto 6
Brussels 5
Bắc Giang 5
Cao Lanh 5
Changsha 5
Genoa 5
Lahore 5
Orem 5
Phủ Lý 5
Pune 5
Shanghai 5
São Paulo 5
Thái Bình 5
Tân Tiến 5
Xi'an 5
Atlanta 4
Bondeno 4
City of London 4
Fort Collins 4
Totale 2.885
Salva come PNG Salva come JPEG
Nome #
Inhibition of microglia over-activation restores neuronal survival and maturation in a mouse model of CDKL5 deficiency disorder 387
Age-related cognitive and motor decline in a mouse model of CDKL5 deficiency disorder is associated with increased neuronal senescence and death 339
Luteolin Treatment Ameliorates Brain Development and Behavioral Performance in a Mouse Model of CDKL5 Deficiency Disorder 288
A GABAB receptor antagonist rescues functional and structural impairments in the perirhinal cortex of a mouse model of CDKL5 deficiency disorder 282
Gut Microbiome Modulation in Hepatocellular Carcinoma: Preventive Role in NAFLD/NASH Progression and Potential Applications in Immunotherapy-Based Strategies 264
Expression of a Secretable, Cell-Penetrating CDKL5 Protein Enhances the Efficacy of Gene Therapy for CDKL5 Deficiency Disorder 247
CDKL5 deficiency predisposes neurons to cell death through the deregulation of SMAD3 signaling (vol 29, pg 658, 2019) 247
Inhibition of microglia overactivation restores neuronal survival in a mouse model of CDKL5 deficiency disorder 240
Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of CDKL5 Deficiency Disorder 234
Increased DNA Damage and Apoptosis in CDKL5-Deficient Neurons 231
MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma 230
Functional and structural impairments in the perirhinal cortex of a mouse model of CDKL5 deficiency disorder are rescued by a TrkB agonist 205
Pharmacotherapy with sertraline rescues brain development and behavior in a mouse model of CDKL5 deficiency disorder 200
Noncoding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response 180
MiR-22/GLUT1 Axis Induces Metabolic Reprogramming and Sorafenib Resistance in Hepatocellular Carcinoma 170
Mir-30e-3p/CXCL3 axis is involved in sorafenib resistance of hepatocellular carcinoma through the modulation of the tumor immune microenvironment 91
miR-30e-3p/CXCL3 axis predicts early tumor escape in sorafenib-treated hepatocellular carcinoma patients. 77
Gut microbiome alterations and lenvatinib resistance in hepatocellular carcinoma: the role of Akkermansia muciniphila postbiotics in treatment enhancement 70
Towards precision medicine: a preliminary collection of patient-derived organoids for the screening of personalised therapies in hepatocellular carcinoma 59
miR-30e-3p/CXCL3 axis predicts early tumor escape in hepatocellular carcinoma patients undergoing sorafenib treatment 58
miR-30e-3p/CXCL3 axis predicts early tumor escape in sorafenib-treated HCC patients. 57
The tumour suppressor miR-22 induces metabolic reprogramming through GLUT1 targeting and represents a possible biomarker of Sorafenib response in Hepatocellular Carcinoma 54
MiR-494 induces metabolic reprogramming through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma 53
MiR-22 downregulation activates HIF-1A pathway and induces tumour progression, metabolic reprogramming and sorafenib resistance in hepatocellular carcinoma 51
CXCL3 is a target of miR-30e-3p and predicts tumor escape in sorafenib-treated HCC patients. 51
MiR-30e-3p plays a dual role in hepatocellular carcinoma and predicts tumour escape to sorafenib Treatment 45
MiR-22-3p targets the G2/M checkpoint inhibitor Wee1 and represents a possible biomarker of TACE response in hepatocellular carcinoma 36
MiR-494 induces metabolic reprogramming through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma 36
MiR-22 regulates HIF-1A pathway and tumor progression and represents a possible biomarker of sorafenib response in hepatocellular carcinoma 34
Totale 4.516
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.300
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.300
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202142 0 0 0 0 0 0 0 0 0 10 1 31
2021/2022332 28 18 28 37 20 13 18 18 17 25 62 48
2022/2023589 31 78 36 45 65 56 24 57 95 14 49 39
2023/2024291 9 21 4 29 12 51 42 40 32 12 13 26
2024/2025627 51 64 57 50 45 29 58 29 18 86 61 79
2025/20262.503 205 344 162 129 155 193 395 149 632 139 0 0
Totale 4.516